Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK.

Nicholson BD, James T, East JE, Grimshaw D, Paddon M, Justice S, Oke JL, Shine B.

Frontline Gastroenterol. 2019 Oct;10(4):347-355. doi: 10.1136/flgastro-2018-101052. Epub 2018 Oct 9.

PMID:
31656559
2.

Electronic, Electrical, and Magnetic Behavioral Change of SiO2-NP-Decorated MWCNTs.

Oke JA, Idisi DO, Sarma S, Moloi SJ, Ray SC, Chen KH, Ghosh A, Shelke A, Pong WF.

ACS Omega. 2019 Aug 26;4(11):14589-14598. doi: 10.1021/acsomega.9b01958. eCollection 2019 Sep 10.

3.

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis.

McLellan J, Bankhead CR, Oke JL, Hobbs FDR, Taylor CJ, Perera R.

BMJ Evid Based Med. 2019 Jul 20. pii: bmjebm-2019-111208. doi: 10.1136/bmjebm-2019-111208. [Epub ahead of print]

PMID:
31326896
4.

Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD.

Feakins B, Oke J, McFadden E, Aronson J, Lasserson D, O'Callaghan C, Taylor C, Hill N, Stevens R, Perera R.

BMJ Open. 2019 Jun 12;9(6):e028062. doi: 10.1136/bmjopen-2018-028062. Erratum in: BMJ Open. 2019 Jul 1;9(7):e028062corr1.

5.

Development of practical recommendations for diagnostic accuracy studies in low-prevalence situations.

Holtman GA, Berger MY, Burger H, Deeks JJ, Donner-Banzhoff N, Fanshawe TR, Koshiaris C, Leeflang MM, Oke JL, Perera R, Reitsma JB, Van den Bruel A.

J Clin Epidemiol. 2019 Oct;114:38-48. doi: 10.1016/j.jclinepi.2019.05.018. Epub 2019 May 28.

PMID:
31150837
6.

Development and validation of clinical prediction models to risk stratify patients presenting with small pulmonary nodules: a research protocol.

Oke JL, Pickup LC, Declerck J, Callister ME, Baldwin D, Gustafson J, Peschl H, Ather S, Tsakok M, Exell A, Gleeson F.

Diagn Progn Res. 2018 Nov 29;2:22. doi: 10.1186/s41512-018-0044-3. eCollection 2018.

7.

Corrigendum to "The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach" [Pregn. Hypertens. 12 (2018) 161-168].

Tucker KL, Bowen L, Crawford C, Mallon P, Hinton L, Lee MM, Oke J, Taylor KS, Heneghan C, Bankhead C, Mackillop L, James T, Oakeshott P, Chappell LC, McManus RJ.

Pregnancy Hypertens. 2019 Apr;16:31. doi: 10.1016/j.preghy.2019.02.005. Epub 2019 Feb 26. No abstract available.

8.

Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16.

O'Sullivan JW, Stevens S, Oke J, Hobbs FDR, Salisbury C, Little P, Goldacre B, Bankhead C, Aronson JK, Heneghan C, Perera R.

BMC Med. 2018 Dec 20;16(1):229. doi: 10.1186/s12916-018-1217-1.

9.

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis.

Oke J, Clements A, McLellan J, Bankhead C, Taylor CJ, Spence G, Banerjee A, Perera R.

Open Heart. 2018 Oct 8;5(2):e000826. doi: 10.1136/openhrt-2018-000826. eCollection 2018.

10.

The mapping of cancer incidence and mortality trends in the UK from 1980-2013 reveals a potential for overdiagnosis.

Oke JL, O'Sullivan JW, Perera R, Nicholson BD.

Sci Rep. 2018 Oct 2;8(1):14663. doi: 10.1038/s41598-018-32844-x.

11.

Trends in Cancer Antigen 125 testing 2003-2014: A primary care population-based cohort study using laboratory data.

Nicholson BD, Lee MM, Wijeratne D, James T, Shine B, Oke JL.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12914. doi: 10.1111/ecc.12914. Epub 2018 Sep 20.

PMID:
30238522
12.

Discharge pathways and relapse following treatment from early intervention in psychosis services.

Puntis S, Oke J, Lennox B.

BJPsych Open. 2018 Aug 30;4(5):368-374. doi: 10.1192/bjo.2018.50. eCollection 2018 Sep.

13.

Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care.

Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, Hamilton W.

Br J Gen Pract. 2018 Sep;68(674):e586-e593. doi: 10.3399/bjgp18X698357. Epub 2018 Aug 13.

14.

Home self-testing kits: helpful or harmful?

Tidy EJ, Shine B, Oke J, Hayward G.

Br J Gen Pract. 2018 Aug;68(673):360-361. doi: 10.3399/bjgp18X698021. No abstract available.

15.

Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.

Koshiaris C, Oke J, Abel L, Nicholson BD, Ramasamy K, Van den Bruel A.

BMJ Open. 2018 Jun 22;8(6):e019758. doi: 10.1136/bmjopen-2017-019758.

16.

Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 May 24;8(1):8354. doi: 10.1038/s41598-018-26376-7.

17.

Reference values for body composition and associations with blood pressure in Kenyan adults aged ≥50 years old.

Bastawrous MC, Piernas C, Bastawrous A, Oke J, Lasserson D, Mathenge W, Burton MJ, Jebb SA, Kuper H.

Eur J Clin Nutr. 2019 Apr;73(4):558-565. doi: 10.1038/s41430-018-0177-z. Epub 2018 May 15.

18.

Kidney age, not kidney disease.

Stevens RJ, Evans J, Oke J, Smart B, Hobbs FDR, Holloway E, Horwood J, Judd M, Locock L, McLellan J, Perera R.

CMAJ. 2018 Apr 3;190(13):E389-E393. doi: 10.1503/cmaj.170674. Review. No abstract available. Erratum in: CMAJ. 2019 Apr 1;191(13):E372.

19.

Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 Mar 19;8(1):4752. doi: 10.1038/s41598-018-23263-z. Erratum in: Sci Rep. 2018 May 24;8(1):8354.

20.

The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer.

Nicholson BD, Oke J, Friedemann Smith C, Phillips JA, Lee J, Abel L, Kelly S, Gould I, Mackay T, Kaveney Z, Anthony S, Hayles S, Lasserson D, Gleeson F.

BMJ Open. 2018 Jan 21;8(1):e018168. doi: 10.1136/bmjopen-2017-018168.

21.

The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach.

Tucker KL, Bowen L, Crawford C, Mallon P, Hinton L, Lee MM, Oke J, Taylor KS, Heneghan C, Bankhead C, Mackillop L, James T, Oakeshott P, Chappell LC, McManus RJ.

Pregnancy Hypertens. 2018 Apr;12:161-168. doi: 10.1016/j.preghy.2017.11.009. Epub 2017 Nov 23. Erratum in: Pregnancy Hypertens. 2019 Apr;16:31.

22.

Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.

Koshiaris C, Aveyard P, Oke J, Ryan R, Szatkowski L, Stevens R, Farley A.

Br J Cancer. 2017 Oct 10;117(8):1224-1232. doi: 10.1038/bjc.2017.179. Epub 2017 Sep 12.

23.

Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer.

Farley A, Koshiaris C, Oke J, Ryan R, Szatkowski L, Stevens R, Aveyard P.

Ann Fam Med. 2017 Sep;15(5):443-450. doi: 10.1370/afm.2100.

24.

NMDAR antibodies in first episode psychosis: conclusions too inflammatory given results? - Authors' reply.

Lee MM, Oke J, Palmer-Cooper EC, Lennox BR.

Lancet Psychiatry. 2017 May;4(5):356-357. doi: 10.1016/S2215-0366(17)30139-6. No abstract available.

PMID:
28456292
25.

Erratum to: Methods for evaluating medical tests and biomarkers.

Gopalakrishna G, Langendam M, Scholten R, Bossuyt P, Leeflang M, Noel-Storr A, Thomas J, Marshall I, Wallace B, Whiting P, Davenport C, Leeflang M, GopalaKrishna G, de Salis I, Mallett S, Wolff R, Whiting P, Riley R, Westwood M, Kleinen J, Collins G, Reitsma H, Moons K, Zapf A, Hoyer A, Kramer K, Kuss O, Ensor J, Deeks JJ, Martin EC, Riley RD, Rücker G, Steinhauser S, Schumacher M, Riley R, Ensor J, Snell K, Willis B, Debray T, Moons K, Deeks J, Collins G, di Ruffano LF, Willis B, Davenport C, Mallett S, Taylor-Phillips S, Hyde C, Deeks J, Mallett S, Taylor SA, Batnagar G; STREAMLINE COLON Investigators; STREAMLINE LUNG Investigators; METRIC Investigators, Taylor-Phillips S, Di Ruffano LF, Seedat F, Clarke A, Deeks J, Byron S, Nixon F, Albrow R, Walker T, Deakin C, Hyde C, Zhelev Z, Hunt H, di Ruffano LF, Yang Y, Abel L, Buchanan J, Fanshawe T, Shinkins B, Wynants L, Verbakel J, Van Huffel S, Timmerman D, Van Calster B, Leeflang M, Zwinderman A, Bossuyt P, Oke J, O'Sullivan J, Perera R, Nicholson B, Bromley HL, Roberts TE, Francis A, Petrie D, Mann GB, Malottki K, Smith H, Deeks J, Billingham L, Sitch A, Mallett S, Deeks J, Gerke O, Holm-Vilstrup M, Segtnan EA, Halekoh U, Høilund-Carlsen PF, Francq BG, Deeks J, Sitch A, Dinnes J, Parkes J, Gregory W, Hewison J, Altman D, Rosenberg W, Selby P, Asselineau J, Perez P, Paye A, Bessede E, Proust-Lima C, Naaktgeboren C, de Groot J, Rutjes A, Bossuyt P, Reitsma J, Moons K, Collins G, Ogundimu E, Cook J, Le Manach Y, Altman D, Wynants L, Vergouwe Y, Van Huffel S, Timmerman D, Van Calster B, Pajouheshnia R, Groenwold R, Moons K, Reitsma J, Peelen L, Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW, Cooper J, Taylor-Phillips S, Parsons N, Stinton C, Smith S, Dickens A, Jordan R, Enocson A, Fitzmaurice D, Sitch A, Adab P, Francq BG, Boachie C, Vidmar G, Freeman K, Connock M, Taylor-Phillips S, Court R, Clarke A, de Groot J, Naaktgeboren C, Reitsma H, Moons C, Harris J, Mumford A, Plummer Z, Lee K, Reeves B, Rogers C, Verheyden V, Angelini GD, Murphy GJ, Huddy J, Ni M, Good K, Cooke G, Bossuyt P, Hanna G, Ma J, Altman D, Collins G, Moons KGMC, de Groot JAH, Mallett S, Altman DG, Reitsma JB, Collins GS, Moons KGM, Altman DG, Reitsma JB, Collins GS, Kamarudin AN, Kolamunnage-Dona R, Cox T, Ni M, Huddy J, Borsci S, Hanna G, Pérez T, Pardo MC, Candela-Toha A, Muriel A, Zamora J, Sanghera S, Mohiuddin S, Martin R, Donovan J, Coast J, Seo MK, Cairns J, Mitchell E, Smith A, Wright J, Hall P, Messenger M, Calder N, Wickramasekera N, Vinall-Collier K, Lewington A, Pajouheshnia R, Damen J, Groenwold R, Moons K, Peelen L, Messenger M, Cairns D, Smith A, Hutchinson M, Wright J, Hall P, Calder N, Sturgeon C, Mitchel L, Kift R, Christakoudi S, Rungall M, Mobillo P, Montero R, Tsui TL, Kon SP, Tucker B, Sacks S, Farmer C, Strom T, Chowdhury P, Rebollo-Mesa I, Hernandez-Fuentes M, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KGM, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Ma J, Altman D, Collins G, Spence G, McCartney D, van den Bruel A, Lasserson D, Hayward G, Vach W, de Jong A, Burggraaff C, Hoekstra O, Zijlstra J, de Vet H, Hunt H, Hyde C, Graziadio S, Allen J, Johnston L, O'Leary R, Power M, Allen J, Graziadio S, Johnson L, O'Leary R, Power M, Waters R, Simpson J, Johnston L, Allen J, Graziadio S, O'Leary R, Waters R, Power M, Mallett S, Fanshawe TR, Phillips P, Plumb A, Helbren E, Halligan S, Taylor SA, Gale A, Mallett S, Sekula P, Altman DG, Sauerbrei W, Mallett S, Fanshawe TR, Forman JR, Dutton SJ, Takwoingi Y, Hensor EM, Nichols TE, Shinkins B, Yang Y, Abel L, Di Ruffano LF, Fanshawe T, Kempf E, Porcher R, de Beyer J, Moons K, Altman D, Reitsma H, Hopewell S, Sauerbrei W, Collins G, Dennis J, Shields B, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L, Shields B, Dennis J, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Scheibler F, Rummer A, Sturtz S, Großelfinger R, Banister K, Ramsay C, Azuara-Blanco A, Cook J, Boachie C, Burr J, Kumarasamy M, Bourne R, Uchegbu I, Borsci S, Murphy J, Hanna G, Uchegbu I, Carter A, Murphy J, Ni M, Marti J, Eatock J, Uchegbu I, Robotham J, Dudareva M, Gilchrist M, Holmes A, Uchegbu I, Borsci S, Monaghan P, Lord S, StJohn A, Sandberg S, Cobbaert C, Lennartz L, Verhagen-Kamerbeek W, Ebert C, Bossuyt P, Horvath A; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens K, Naaktgeboren C, Reitsma J, Moons K, de Groot J, Hyde C, Peters J, Grigore B, Peters J, Hyde C, Hyde C, Ukoumunne O, Peters J, Zhelev Z, Levis B, Benedetti A, Levis AW, Ioannidis JPA, Shrier I, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Steele RJ, Ziegelstein RC, Bombardier CH, Osório FL, Fann JR, Gjerdingen D, Lamers F, Lotrakul M, Loureiro SR, Löwe B, Shaaban J, Stafford L, van Weert HCPM, Whooley MA, Williams LS, Wittkampf KA, Yeung AS, Thombs BD, Peters J, Cooper C, Buchanan J, Nieto T, Smith C, Tucker O, Dretzke J, Beggs A, Rai N, Davenport C, Bayliss S, Stevens S, Snell K, Mallet S, Deeks J, Sundar S, Hall E, Porta N, Estelles DL, de Bono J; CTC-STOP protocol development group.

Diagn Progn Res. 2017 Mar 30;1:11. doi: 10.1186/s41512-017-0011-4. eCollection 2017.

26.

Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.

Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T.

BMJ. 2017 Jan 4;356:i6538. doi: 10.1136/bmj.i6538. Review.

PMID:
28052845
27.
28.

Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Nicholson BD, Oke JL, Rose PW, Mant D.

PLoS One. 2016 Jul 22;11(7):e0159725. doi: 10.1371/journal.pone.0159725. eCollection 2016.

29.

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD.

PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016. Review.

30.

Trends in serum creatinine testing in Oxfordshire, UK, 1993-2013: a population-based cohort study.

Oke J, Shine B, McFadden E, Stevens R, Lasserson D, Perera R.

BMJ Open. 2015 Dec 16;5(12):e009459. doi: 10.1136/bmjopen-2015-009459.

31.

The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.

Oke JL, Stratton IM, Aldington SJ, Stevens RJ, Scanlon PH.

Diabet Med. 2016 Jul;33(7):896-903. doi: 10.1111/dme.13053. Epub 2016 Jan 10.

32.

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, Gazis A, Stratton IM.

Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.

33.

Comment on: 'Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960'--cancer predictions need more context.

Oke JL, Nicholson BD, Shinkins B.

Br J Cancer. 2015 Dec 1;113(11):1632. doi: 10.1038/bjc.2015.219. Epub 2015 Jun 23. No abstract available.

34.

People's willingness to accept overdetection in cancer screening: population survey.

Van den Bruel A, Jones C, Yang Y, Oke J, Hewitson P.

BMJ. 2015 Mar 3;350:h980. doi: 10.1136/bmj.h980.

35.

Cancer survival figures are misleading.

Oke JL.

BMJ. 2014 May 19;348:g3315. doi: 10.1136/bmj.g3315. No abstract available.

PMID:
24840236
36.

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.

Farmer AJ, Stevens R, Hirst J, Lung T, Oke J, Clarke P, Glasziou P, Neil A, Dunger D, M Colhoun H, Pugh C, Wong G, Perera R, Shine B.

Health Technol Assess. 2014 Feb;18(14):1-128. doi: 10.3310/hta18140. Review.

37.

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.

Oke J, Farmer A, Neil A, Dalton RN, Dunger D, Stevens R.

Diabetes Res Clin Pract. 2013 Mar;99(3):307-14. doi: 10.1016/j.diabres.2012.12.010. Epub 2013 Jan 9.

PMID:
23312483
38.

An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes.

Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, Oke J, Boase S, Selwood M, Kellar I, Graffy J, Griffin S, Sutton S, Kinmonth AL.

BMC Fam Pract. 2012 Apr 5;13:30. doi: 10.1186/1471-2296-13-30.

39.

Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.

Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S.

BMJ. 2012 Feb 27;344:e486. doi: 10.1136/bmj.e486.

PMID:
22371867
40.

Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.

Oke JL, Stevens RJ, Gaitskell K, Farmer AJ.

Diabet Med. 2012 Feb;29(2):266-71. doi: 10.1111/j.1464-5491.2011.03412.x.

PMID:
21838767
41.

Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.

Farmer AJ, Oke J, Stevens R, Holman RR.

Diabetes Obes Metab. 2011 Dec;13(12):1136-41. doi: 10.1111/j.1463-1326.2011.01475.x.

PMID:
21767341
42.

Statistical models for the control phase of clinical monitoring.

Stevens RJ, Oke J, Perera R.

Stat Methods Med Res. 2010 Aug;19(4):394-414. doi: 10.1177/0962280209359886. Epub 2010 May 4.

PMID:
20442195
43.

Virus succession observed during an Emiliania huxleyi bloom.

Schroeder DC, Oke J, Hall M, Malin G, Wilson WH.

Appl Environ Microbiol. 2003 May;69(5):2484-90.

44.

Coccolithovirus (Phycodnaviridae): characterisation of a new large dsDNA algal virus that infects Emiliana huxleyi.

Schroeder DC, Oke J, Malin G, Wilson WH.

Arch Virol. 2002 Sep;147(9):1685-98.

PMID:
12209309
45.

[The risk of malaria transmission by blood transfusion at Cotonou, Benin].

Kinde-Gazard, Oke J, Gnahoui I, Massougbodji A.

Sante. 2000 Nov-Dec;10(6):389-92.

46.

A Definitive Optical Detection of a Supercluster at z approximately 0.91.

Lubin LM, Brunner R, Metzger MR, Postman M, Oke JB.

Astrophys J. 2000 Mar 1;531(1):L5-L8.

PMID:
10673401
47.

Trehalose-6-phosphate-potent anti-onchocerciatic agent.

Oke JM, Watt RA.

Afr J Med Med Sci. 1998 Sep-Dec;27(3-4):225-8.

PMID:
10497654
48.

Hypoglycaemic activity of alpha, alpha trehalose-6-phosphate.

Oke JM, Watt RA.

Afr J Med Med Sci. 1998 Sep-Dec;27(3-4):219-23.

PMID:
10497653
49.

The oral hypoglycemic activity of 2,5-dioxamide derivatives of 1,3,4-thiadiazole.

Oke JM, Olowookorun MO.

Jpn J Pharmacol. 1989 Jan;49(1):135-8.

50.

A practical multiple reflection technique for improving the quantum efficiency of photomultiplier tubes.

Oke JB, Schild RE.

Appl Opt. 1968 Apr 1;7(4):617-22. doi: 10.1364/AO.7.000617.

PMID:
20068647

Supplemental Content

Support Center